State of New Jersey Common Pension Fund D
AIMT

State of New Jersey Common Pension Fund D’s Aimmune Therapeutics AIMT Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-79,704
Closed -$1.15M – 1737
2020
Q1 		$1.15M Hold
79,704
– – 0.01% 1383
2019
Q4 		$2.67M Sell
79,704
-41,396
-34% -$1.16M 0.01% 1109
2019
Q3 		$2.54M Buy
+121,100
New +$2.47M 0.01% 1158

Other funds holding AIMT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State of New Jersey Common Pension Fund D's AIMT Position: Q2 2020 in Review

State of New Jersey Common Pension Fund D sold out of Aimmune Therapeutics (AIMT) in Q2 2020, closing a stake of 79,704 shares — an estimated $1.15M sold.

State of New Jersey Common Pension Fund D first reported a position in AIMT in Q3 2019 and held it in 3 quarters. The position peaked at $2.67M in Q4 2019. 165 funds tracked by Wall St. Rank hold AIMT as of Q2 2020.

  • State of New Jersey Common Pension Fund D reported no remaining Aimmune Therapeutics position as of Q2 2020 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 79,704 Aimmune Therapeutics shares in Q2 2020, an estimated $1.15M.
  • State of New Jersey Common Pension Fund D first reported a position in Aimmune Therapeutics in Q3 2019 and held it in 3 quarters.
  • State of New Jersey Common Pension Fund D's Aimmune Therapeutics position peaked at $2.67M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q2 2020.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2020, filed 4 Aug 2020.